mTORC2 aging describes age-related changes in mechanistic target of rapamycin complex 2 signaling, which regulates insulin signaling, cytoskeletal organization, and metabolic balance. Aging alters mTORC2 activity, impairing insulin sensitivity and cellular survival signaling. Disruption of mTORC2 aging affects glucose uptake, lipid metabolism, and stress response pathways. Reduced mTORC2 function contributes to metabolic decline and tissue dysfunction. Understanding mTORC2 aging complements mTORC1 research by revealing distinct roles of mTOR complexes in aging regulation.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom